Cargando…

Breast cancer in schizophrenia could be interleukin-33-mediated

Recent epidemiological and genetic studies have revealed an interconnection between schizophrenia and breast cancer. The mutual underlying pathophysiological mechanisms may be immunologically driven. A new cluster of molecules called alarmins may be involved in sterile brain inflammation, and we hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borovcanin, Milica M, Vesic, Katarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613763/ https://www.ncbi.nlm.nih.gov/pubmed/34888174 http://dx.doi.org/10.5498/wjp.v11.i11.1065

Ejemplares similares

Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
por: Borovcanin, Milica M, et al.
Publicado: (2021)

Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses
por: Vesic, Katarina, et al.
Publicado: (2023)

The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction
por: Mijailovic, Natasa R., et al.
Publicado: (2022)

Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
por: Borovcanin, Milica M., et al.
Publicado: (2022)

Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
por: Borovcanin, Milica M., et al.
Publicado: (2022)

Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
por: Mijailović, Nataša R., et al.
Publicado: (2022)

Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders
por: Borovcanin, Milica M, et al.
Publicado: (2023)

Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential
por: Huang, Fang, et al.
Publicado: (2022)

Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
por: Borovcanin, Milica Milovan, et al.
Publicado: (2017)

Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of Depressiveness
por: Borovcanin, Milica M., et al.
Publicado: (2023)

Legume–rhizobium dance: an agricultural tool that could be improved?
por: Basile, Laura A., et al.
Publicado: (2021)

Could there be an interplay between periodontal changes and pancreatic malignancies?
por: Ungureanu, Bogdan Silviu, et al.
Publicado: (2023)

Plant synthetic biology could drive a revolution in biofuels and medicine
por: Mortimer, Jenny C
Publicado: (2018)

Opportunistic diseases in marine eukaryotes: Could Bacteroidota be the next threat to ocean life?
por: Hudson, Jennifer, et al.
Publicado: (2022)

Common variants in polygenic schizophrenia
por: Glessner, Joseph T, et al.
Publicado: (2009)

Advances on the Role and Applications of Interleukin-1 in Tuberculosis
por: Silvério, Diogo, et al.
Publicado: (2021)

Developments in the Dehydrogenative Electrochemical Synthesis of 3,3′,5,5′‐Tetramethyl‐2,2′‐biphenol
por: Gleede, Barbara, et al.
Publicado: (2021)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

Genome scans and microarrays: converging on genes for schizophrenia?
por: Williams, Nigel M, et al.
Publicado: (2002)

Searching for the true genetic vulnerability for schizophrenia
por: DeLisi, Lynn E
Publicado: (2009)

Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics
por: Banerjee, Arnab, et al.
Publicado: (2021)

Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health?
por: Jadzic, Jelena, et al.
Publicado: (2023)

Social media and schizophrenia: An update on clinical applications
por: Fonseka, Lakshan N, et al.
Publicado: (2022)

Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic Neisseria
por: Goytia, Maira, et al.
Publicado: (2022)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

Differences between delusional disorder and schizophrenia: A mini narrative review
por: González-Rodríguez, Alexandre, et al.
Publicado: (2022)

Reasons for breast cancer heterogeneity
por: Bertucci, François, et al.
Publicado: (2008)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Epidemiology of soy exposures and breast cancer risk
por: Wu, A H, et al.
Publicado: (2008)

Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
por: Minic Janicijevic, Slavica, et al.
Publicado: (2022)

Mammographic density, lobular involution, and risk of breast cancer
por: Ginsburg, O M, et al.
Publicado: (2008)

Could Interleukin-33 (IL-33) Govern the Outcome of an Equine Influenza Virus Infection? Learning from Other Species
por: Rozario, Christoforos, et al.
Publicado: (2021)

Preclinical mouse models for BRCA1-associated breast cancer
por: Drost, R M, et al.
Publicado: (2009)

Genomic approaches in the management and treatment of breast cancer
por: Chang, J C, et al.
Publicado: (2005)

Molecular profiling of breast cancer: clinical implications
por: Cleator, S, et al.
Publicado: (2004)

Variants in the ATM gene and breast cancer susceptibility
por: Milne, Roger L
Publicado: (2009)

Gene–environment interaction and risk of breast cancer
por: Rudolph, Anja, et al.
Publicado: (2016)

Relevance of tumor-infiltrating lymphocytes in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2015)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hj3ka79d493uboeamr61hvg6dt